In This Article: Further information about Puma Biotechnology may be found at https://www.pumabiotechnology.com . View source version on businesswire.com: https://www.businesswire.com/news/home/20250305372281/en/ Contacts Alan H. Auerbach or Mariann Ohanesian, Puma Biotechnology, Inc., +1 424 248 6500 info@pumabiotechnology.com ir@pumabiotechnology.com David Schull or Olipriya Das, Russo Partners, +1 212 845 4200 david.schull@russopartnersllc.com olipriya.das@russopartnersllc.com
Puma Biotechnology is a California-based biopharmaceutical company that develops and commercializes novel therapeutics for the treatment of HER2+ breast cancer patients.